Poster Presentations

Selinexor

Survival Among Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Single Agent Selinexor in the SADAL Study

Marie Maerevoet, Institute Jules Bordet
EP1260
19. Aggressive Non-Hodgkin lymphoma – Clinical

Efficacy and Safety of Single Agent Oral Selinexor in Patients with Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the SADAL Study

Josee Zijlstra, Amsterdam Universitair Medische Centra, Vrije Universiteit, Cancer Center
EP1226
19. Aggressive Non-Hodgkin lymphoma – Clinical

Effect of Prior Therapy on the Efficacy and Safety Of Oral Selinexor in Patients With Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study

George Follows, Addenbrooke’s Hospital, Cambridge, United Kingdom
EP1244
19. Aggressive Non-Hodgkin lymphoma – Clinical

Inhibition of XPO1 and eIF4E Prevents Protein Translation resulting in Synergistic Anti-Myeloma Effects

Shirong Li, Columbia University
EP1910
13. Myeloma and other monoclonal gammopathies – Biology & Translational Research

IDH2 p.R172K Mutations in Patients with Acute Myeloid Leukemia (AML) May Be Associated with Favorable Response to Selinexor Treatment

Christopher J. Walker, Karyopharm Therapeutics Inc.
EP484
03. Acute myeloid leukemia – Biology & Translational Research

Comprehensive Assessment of Molecular Markers of Selinexor Response in Patients with Diffuse Large B-cell Lymphoma (DLBCL)

Christopher Walker, Karyopharm Therapeutics
EP1328
20. Lymphoma Biology & Translational Research

Click Here for the Selinexor Abstracts Located on the EHA Meeting Library

Eltanexor

Continuous XPO1 Inhibition with Eltanexor is Highly Effective in NPM1-mutated AML In Vivo

Giulia Pianigiani, University of Perugia
EP441
03. Acute myeloid leukemia – Biology & Translational Research

RNA and DNA Sequencing Reveal Markers of Response to the XPO1 Inhibitor Eltanexor in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

Christopher Walker, Karyopharm Therapeutics
EP890
13. Myeloma and other monoclonal gammopathies – Biology & Translational Research

Click Here for the Eltanexor Abstracts Located on the EHA Meeting Library

L